Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
出版年份 2021 全文链接
标题
Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-27
DOI
10.1007/s00228-021-03160-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study
- (2021) Filippa Juul et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ultra-processed food and the risk of overweight and obesity: a systematic review and meta-analysis of observational studies
- (2020) Mohammadreza Askari et al. INTERNATIONAL JOURNAL OF OBESITY
- Cardiovascular outcome trials in obesity: A review
- (2020) John P.H. Wilding et al. Obesity Reviews
- Ultra-processed food consumption is associated with increased risk of all-cause and cardiovascular mortality in the Moli-sani Study
- (2020) Marialaura Bonaccio et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial
- (2019) Dario Tuccinardi et al. DIABETES OBESITY & METABOLISM
- Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
- (2019) Jean Strelitz et al. DIABETOLOGIA
- Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: a meta-analysis of randomised trials
- (2019) Navneet Singh et al. BMJ Open
- Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events
- (2019) Subodh Verma et al. JAMA Cardiology
- Cardiometabolic Effects of Anti-obesity Pharmacotherapy
- (2018) Andrew R. Crawford et al. Current Atherosclerosis Reports
- Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis
- (2018) Rohan Khera et al. GASTROENTEROLOGY
- Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update
- (2018) Marie-Eve Piché et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
- (2018) Erin A. Bohula et al. NEW ENGLAND JOURNAL OF MEDICINE
- Suicidal ideation is associated with cardiovascular disease in a large, urban cohort of adults in the Southern Cone of Latin America
- (2018) Federico M. Daray et al. GENERAL HOSPITAL PSYCHIATRY
- Obesity and cardiovascular disease: revisiting an old relationship
- (2018) Chrysi Koliaki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- Current pharmacotherapy for obesity
- (2017) Gitanjali Srivastava et al. Nature Reviews Endocrinology
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
- (2017) Chenhan Ma et al. BMJ-British Medical Journal
- Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
- (2017) Chenhan Ma et al. BMJ-British Medical Journal
- GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway
- (2016) Qin He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
- (2016) W. Timothy Garvey et al. Endocrine Practice
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- School Year Versus Summer Differences in Child Weight Gain: A Narrative Review
- (2016) Tom Baranowski et al. Childhood Obesity
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is exclusive breastfeeding and its duration related to cardio respiratory fitness in childhood?
- (2015) Mohammadreza Vafa et al. Journal of Maternal-Fetal & Neonatal Medicine
- Depression, anxiety and 6-year risk of cardiovascular disease
- (2015) Adrie Seldenrijk et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Intentional Weight Loss and All-Cause Mortality: A Meta-Analysis of Randomized Clinical Trials
- (2015) Stephen B. Kritchevsky et al. PLoS One
- Effects of Low-Carbohydrate and Low-Fat Diets
- (2014) Lydia A. Bazzano et al. ANNALS OF INTERNAL MEDICINE
- Assessment and Lifestyle Management of Patients With Obesity
- (2014) Robert F. Kushner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Five-year weight changes associate with blood pressure alterations independent of changes in serum insulin
- (2014) Ekim Seven et al. JOURNAL OF HYPERTENSION
- Preface to the full report
- (2014) Donna Ryan et al. Obesity
- Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
- (2014) Ian Caterson et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Depression and cardiovascular disease: a clinical review
- (2013) D. L. Hare et al. EUROPEAN HEART JOURNAL
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of Weight Reduction Therapy on Obstructive Sleep Apnea Syndrome and Arterial Stiffness in Patients with Obesity and Metabolic Syndrome
- (2013) Azusa Iguchi et al. Journal of Atherosclerosis and Thrombosis
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study
- (2013) Morten Schmidt et al. BMJ Open
- Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
- (2011) I. D. Caterson et al. DIABETES OBESITY & METABOLISM
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started